APA

Panés J., Sandborn W. J., Schreiber S., Sands B. E., Vermeire S., D'Haens G., Panaccione R., Higgins P. D. R., Colombel J., Feagan B. G., Chan G., Moscariello M., Wang W., Niezychowski W., Marren A., Healey P. & Maller E. (20170803). Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials. : Gut.

Chicago

Panés Julian, Sandborn William J, Schreiber Stefan, Sands Bruce E, Vermeire Séverine, D'Haens Geert, Panaccione Remo, Higgins Peter D R, Colombel Jean-Frederic, Feagan Brian G, Chan Gary, Moscariello Michele, Wang Wenjin, Niezychowski Wojciech, Marren Amy, Healey Paul and Maller Eric. 20170803. Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials. : Gut.

Harvard

Panés J., Sandborn W. J., Schreiber S., Sands B. E., Vermeire S., D'Haens G., Panaccione R., Higgins P. D. R., Colombel J., Feagan B. G., Chan G., Moscariello M., Wang W., Niezychowski W., Marren A., Healey P. and Maller E. (20170803). Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials. : Gut.

MLA

Panés Julian, Sandborn William J, Schreiber Stefan, Sands Bruce E, Vermeire Séverine, D'Haens Geert, Panaccione Remo, Higgins Peter D R, Colombel Jean-Frederic, Feagan Brian G, Chan Gary, Moscariello Michele, Wang Wenjin, Niezychowski Wojciech, Marren Amy, Healey Paul and Maller Eric. Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials. : Gut. 20170803.